Electromagnetic Field Protection Device Use Impact in Healthy Volunteers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-31

Study Completion Date

2023-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, single group, self-controlled study to evaluate the clinical and molecular impact of continuous in-home resonance-based electromagnetic field (EMF) protection device usage in healthy individuals.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Pulsed Electromagnetic Field Therapy on Patients With Low Back Pain

NCT03053375

Low Back Pain

UNKNOWN NA

Effect of Electromagnetic Therapy on Patients With Chronic Rhinosinusitis.

NCT05865613

Magnetic Therapy Rhinosinusitis Headache +1 more

COMPLETED NA

Efficacy and Safety of Weak Extremely Low Frequency Electromagnetic Fields in Mild and Moderate Essential Hypertension

NCT00709930

Essential Hypertension

COMPLETED PHASE2

Validation of New Devices Against Ambient Electromagnetic Radiation

NCT04541459

Male Infertility

UNKNOWN EARLY_PHASE1

Pulsed Electromagnetic Fields for Multiple Chemical Sensitivity

NCT01834781

Multiple Chemical Sensitivity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging Well Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

In-home EMF protection device

Group Type EXPERIMENTAL

In-home resonance-based electromagnetic field protection device

Intervention Type DEVICE

Participants will have an in-home EMF protection device

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

In-home resonance-based electromagnetic field protection device

Participants will have an in-home EMF protection device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any sex, gender orientation, and ethnicity
* Between ages 30 and 70
* Must be willing and able to participate in venipuncture, health history and clinical assessments, passive monitoring (Oura ring), and continuous in-home Blushield device usage

Exclusion Criteria

* Significant change in diagnosis and/or treatment of major illness or injury within 2 years prior to screening, e.g., diabetes, cancer, cardiovascular disease, psychiatric condition 2. Any ongoing immune system concerns or immunodeficiency disease
* History of any viral illness in preceding year
* Body mass index (BMI) \> 35 kg/m2
* Presence of active infection
* Any other illness, disorder, alcohol or chemical dependence that in the opinion of investigators would render study participation unsuitable
* Unable or unwilling to provide required biological sample
* Unable or unwilling to avoid pregnancy during study period

Minimum Eligible Age

30 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes